| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.39 | 0.0008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |